Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: K
Results 1 - 10 of 77 shown below

  • K- ras mutations

    J M Garcia, R Gonzalez, J M Silva, G Dominguez, I S Vegazo, C Gamallo, M Provencio, P España and F Bonilla

    Mutational status of K- ras and TP53 genes in primary sarcomas of the heart

    doi:10.1054/bjoc.1999.1060

    Abstract | Full article | PDF

  • K-cadherin

    G Ronzitti, F Callegari, C Malaguti and G P Rossini

    Selective disruption of the E-cadherin–catenin system by an algal toxin

    doi:10.1038/sj.bjc.6601640

    Abstract | Full article | PDF

  • K-Ras

    K Kato, Y Hitomi, K Imamura and H Esumi

    Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells

    doi:10.1038/sj.bjc.6600563

    Abstract | Full article | PDF

  • S Jones, S Lambert, G T Williams, J M Best, J R Sampson and J P Cheadle

    Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas

    advance online publication, 2004-03-30 00:00:00.000;

    doi:10.1038/sj.bjc.6601747

    Abstract | Full article | PDF

  • T Hachisuga, H Tsujioka, S Horiuchi, T Udou, M Emoto and T Kawarabayashi

    K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene

    advance online publication, 2005-03-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602456

    Abstract | Full article | PDF

  • M Sonobe, T Manabe, H Wada and F Tanaka

    Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma

    advance online publication, 2005-07-26 00:00:00.000;

    doi:10.1038/sj.bjc.6602707

    Abstract | Full article | PDF

  • K Sugio, H Uramoto, K Ono, T Oyama, T Hanagiri, M Sugaya, Y Ichiki, T So, S Nakata, M Morita and K Yasumoto

    Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking

    doi:10.1038/sj.bjc.6603040

    Abstract | Full article | PDF

  • Y Tajima, K Yamazaki, R Makino, N Nishino, Y Masuda, S Aoki, M Kato, K Morohara and M Kusano

    Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach

    advance online publication, 2007-01-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603583

    Abstract | Full article | PDF

  • M Frattini, P Saletti, E Romagnani, V Martin, F Molinari, M Ghisletta, A Camponovo, L L Etienne, F Cavalli and L Mazzucchelli

    PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

    advance online publication, 2007-10-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604009

    Abstract | Full article | PDF

  • A Kalikaki, A Koutsopoulos, M Trypaki, J Souglakos, E Stathopoulos, V Georgoulias, D Mavroudis and A Voutsina

    Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

    advance online publication, 2008-08-26 00:00:00.000;

    doi:10.1038/sj.bjc.6604629

    Abstract | Full article | PDF

  • F Molinari, V Martin, P Saletti, S De Dosso, A Spitale, A Camponovo, A Bordoni, S Crippa, L Mazzucchelli and M Frattini

    Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant

    advance online publication, 2009-03-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604848

    Abstract | Full article | PDF

  • H Allgayer, H Wang, S Shirasawa, T Sasazuki and D Boyd

    Targeted disruption of the K-Ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis

    doi:10.1038/sj.bjc.6690616

    Abstract | Full article | PDF

  • P S Moore, S Orlandini, G Zamboni, P Capelli, G Rigaud, M Falconi, C Bassi, N R Lemoine and A Scarpa

    Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis

    doi:10.1054/bjoc.2000.1567

    Abstract | Full article | PDF

  • S Shimada, K Shiomori, S Tashima, J Tsuruta and M Ogawa

    Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas

    doi:10.1054/bjoc.2001.1824

    Abstract | Full article | PDF

  • K-ras mutants

    C-H Wu, Y-F Chen, J-Y Wang, M-C Hsieh, C-S Yeh, S-T Lian, S-J Shin and S-R Lin

    Mutant K-ras oncogene regulates steroidogenesis of normal human adrenocortical cells by the RAF-MEK-MAPK pathway

    doi:10.1038/sj.bjc.6600589

    Abstract | Full article | PDF

  • S-R Lin, C-H Hsu, J-H Tsai, J-Y Wang, T-J Hsieh and C-H Wu

    Decreased GTPase activity of K- ras mutants deriving from human functional adrenocortical tumours

    doi:10.1054/bjoc.1999.1039

    Abstract | Full article | PDF

  • k-ras mutation

    K S Kraunz, H H Nelson, M Liu, J K Wiencke and K T Kelsey

    Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer

    advance online publication, 2005-09-20 00:00:00.000;

    doi:10.1038/sj.bjc.6602790

    Abstract | Full article | PDF

  • K562

    T Asano, K Nakamura, H Fujii, N Horichi, T Ohmori, K Hasegawa, T Isoe, M Adachi, N Otake and Y Fukunaga

    Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation

    advance online publication, 2005-03-29 00:00:00.000;

    doi:10.1038/sj.bjc.6602498

    Abstract | Full article | PDF

  • J M Sargent, C J Williamson, C Yardley, C G Taylor and K Hellmann

    Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562

    doi:10.1054/bjoc.2001.1697

    Abstract | Full article | PDF

  • KAI1/CD82

    H Hashida, A Takabayashi, T Tokuhara, N Hattori, T Taki, H Hasegawa, S Satoh, N Kobayashi, Y Yamaoka and M Miyake

    Clinical significance of transmembrane 4 superfamily in colon cancer

    doi:10.1038/sj.bjc.6601015

    Abstract | Full article | PDF

  • S Uchida, Y Shimada, G Watanabe, Z Gang Li, T Hong, M Miyake and M Imamura

    Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma

    doi:10.1038/sj.bjc.6690186

    Abstract | Full article | PDF

  • kallikrein

    F Fritzsche, T Gansukh, C A Borgoño, M Burkhardt, S Pahl, E Mayordomo, K-J Winzer, W Weichert, C Denkert, K Jung, C Stephan, M Dietel, E P Diamandis, E Dahl and G Kristiansen

    Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status

    advance online publication, 2006-01-24 00:00:00.000;

    doi:10.1038/sj.bjc.6602956

    Abstract | Full article | PDF

  • L-Y Luo, E Rajpert-De Meyts, K Jung and E P Diamandis

    Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue

    doi:10.1054/bjoc.2001.1870

    Abstract | Full article | PDF

  • kallikrein 6

    B R Hoffman, D Katsaros, A Scorilas, P Diamandis, S Fracchioli, I A Rigault de la Longrais, T Colgan, M Puopolo, G Giardina, M Massobrio and E P Diamandis

    Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

    doi:10.1038/sj.bjc.6600533

    Abstract | Full article | PDF

  • kallikrein gene 5

    H Kim, A Scorilas, D Katsaros, G M Yousef, M Massobrio, S Fracchioli, R Piccinno, G Gordini and E P Diamandis

    Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

    doi:10.1054/bjoc.2000.1649

    Abstract | Full article | PDF